Thorvardur Halfdanarson, MD, associate professor of medicine and consultant in medical oncology, Mayo Clinic, outlines the biggest management challenges in neuroendocrine tumors (NETs).
Thorvardur Halfdanarson, MD, associate professor of medicine and consultant in medical oncology, Mayo Clinic, outlines the biggest management challenges in neuroendocrine tumors (NETs).
Transcript
What are the biggest management challenges in neuroendocrine tumors?
One of the bigger management challenges is access to care and access to specialists, ad that doesn’t mean that everyone needs to be managed by a NET specialist, because they absolutely don’t. But, I think all NET patients should at least be given the option of visiting with a NET specialist just to discuss the natural history of the disease and to discuss treatments that might be available, and I think also, at the time of progression, we should really try to get these patients to see a NET specialist to discuss the different treatment options out there, including clinical trials.
So, I think access to NET specialists, because there are not that many of them, is still an issue. Insurance is an issue for some agents, high copayments for certain agents. We have to see how things play out with PRRT [peptide receptor radionuclide therapy] and insurance reimbursement. But, that would be access and the financial toxicity or direct cost to the patient would be the things on the top of my mind.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More